drugset / Trial / NCT05038631

Managed Access Programs for LEE011, Ribociclib

NCT05038631 ↗

Expanded access Available Novartis Pharmaceuticals

Summary

The purpose of this registration is to list Managed Access Programs (MAPs) related to LEE011, Ribociclib

Timeline

Start
—
Primary completion
—
Completion
—

Drugs

EvaluationDrugModalityDoseRoute
Background Ribociclib Small molecule — —

Indications